Trial Profile
A Dipeptidyl Peptidase 4 (DPP-4) Inhibitor in Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 07 Dec 2015 Primary endpoint (Adrenaline levels) has not been met as results published in the Diabetic Medicine.
- 07 Dec 2015 Results published in the Diabetic Medicine
- 17 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.